Two vacancies have arisen for veterinary surgeons to join the Royal College of Veterinary Surgeons' Veterinary Nurses Council.
The positions, which are open to veterinary surgeons not currently serving on RCVS Council, would be particularly well suited to those veterinary surgeons who have an interest in the nursing profession and some experience of working with nurses. However, applicants need not necessarily be politically involved with the profession at this point.
VN Council Chairman Liz Branscombe said: "Veterinary nurses play a vital role in the practice team and, with the opening of the non-statutory Register in 2007, the VN profession is now recognising its responsibilities in terms of maintaining professional standards, skills and competence.
"Now, more than ever, it is important that vets from all sectors of the profession take the time to get involved with the regulation and development of the role of the veterinary nurse."
Applications are invited from all veterinary surgeons, although those with some experience of working with veterinary nurses would be most relevant.
The four-year posts will require an annual time commitment of approximately six to ten days.
For an application pack, please contact Annette Amato, Deputy Head of Veterinary Nursing, on 020 7202 0713 or a.amato@rcvs.org.uk. The deadline for the receipt by RCVS of completed application packs is 30 April 2011.
VetSurgeon member Viki Edmondson MRCVS is taking part in a drive to help 13-year-old Octavia Woodward, who was born with spinal muscular atrophy (SMA), raise £100,000 to help The SMA Trust.
Viki, a well-known vet in the carriage driving world, will be joining Octavia on 'Octavia's Mad Marathon', a five-day, 110 mile carriage drive from Windsor to Wincanton.
Octavia will be driving her pony, Diddy, with her mother Henrietta as co-driver. Meanwhile, Viki will be driving a pair of Gelderlander horses. They'll be leaving the main ring at the Royal Windsor Horse Show with a support crew at 3:30pm on 13th May.
Viki graduated from Bristol Veterinary School in 1993. Since 2001 she has run her own equine practice plus a small animal surgery from the Newdigate, Surrey farm she shares with husband Peter. Viki has known Octavia since she was born and it was Viki who paired up Diddy with Octavia and encouraged her to progress from walking round the roads to the excitement of "off-roading". Viki will be providing support and encouragement to Octavia during the trip - of course with any veterinary help being close by.
To support Viki and Octavia, visit: http://www.justgiving.com/vikithevet
Bayer Animal Health, maker of Advantage, has produced a new animation to educate pet owners about fleas.
The three minute animation, which is available on YouTube (below), is also available from Bayer for practices to play in the waiting room.
For a copy of the animation, contact your local Bayer Animal Health Territory Manager. More information is also available at http://www.advantagespoton.co.uk/.
The President of the British Veterinary Association has written to the Badger Trust to clarify the BVA position on the pilot badger culls in England, stating that it will not be supporting the Trust's application for a judicial review.
The BVA Council agreed a position on the continuation of controlled shooting in the pilot areas on 16 April. The position states that the BVA could only support further culling using controlled shooting in the pilot areas if steps are taken to improve both its effectiveness and humaneness and if there is robust monitoring and collation of results and independent analysis and auditing by a non-governmental body. It also states that the BVA supports the Independent Expert Panel's (IEP) recommendations for improving effectiveness and humaneness and urges Defra to implement all the IEP's recommendations fully.
The BVA says that since 16 April, it has been in dialogue with Defra to seek assurances that these issues will be addressed, and those discussions are ongoing. It will not be taking a further position on the pilot culls until BVA Council has had the opportunity to consider Defra's plans in full, when they are made available.
In a press release dated 20th May, The Badger Trust CEO Dominic Dyer said: "It is not acceptable for the DEFRA Secretary of State to now push aside the concerns of both the Independent Expert Panel and the British Veterinary Association, by moving ahead with a further badger cull in Gloucestershire and Somerset this summer without any independent monitoring in place."
The BVA says it is concerned that this misrepresents its position, and has led to some media reports suggesting that the BVA has withdrawn its support for badger culling as part of the overall strategy to eradicate bovine TB. It has not. The BVA says it continues to believe that the TB eradication strategy for England will only be successful if we are able to use all of the available tools, including targeted, humane badger culling.
Academics from the University of Bristol's School of Veterinary Sciences and the neurology team at Southmead Hospital Bristol have published the results of study examining the use of percutaneous electrical nerve stimulation (PENS) therapy as a treatment for headshaking syndrome in horses.
The authors say that the condition, a neuropathic facial pain syndrome, often leaves affected horses impossible to ride and dangerous to handle, and can result in euthanasia. At present there are no consistently safe and effective methods for the treatment of headshaking in horses, and the condition is estimated to affect between 10,000 and 20,000 horses in the UK.
The study, which is published in the Equine Veterinary Journal (EVJ), aimed to discover whether PENS therapy, developed by Algotec Research and Development Ltd, is safe, effective and sustainable for the management of trigeminal-mediated headshaking in horses.
Seven horses diagnosed with trigeminal-mediated headshaking were recruited to the trial. All procedures were carried out in sedated horses with a needle-prick sized area of skin desensitised with local anaesthetic to help probe insertion. A disposable PENS probe was placed just beneath the skin adjacent to the nerve under ultrasonographic guidance. The nerve was stimulated for 25 minutes following a protocol of alternating frequencies and a perception threshold based on human clinical data. The probe was removed and the procedure repeated on the other side. Three or four treatments were used during the protocol, with treatments being repeated when signs of headshaking recurred.
All horses tolerated the procedure well. Three horses developed a haematoma at the site on one occasion and two had increased clinical signs for up to three days following first treatment. Six horses responded well after the first treatment and returned to ridden work at the same level before headshaking began. Five horses continued to respond to further treatment.
Veronica Roberts, Senior Clinical Fellow in Equine Medicine in the University's School of Veterinary Sciences, who led the study, said: "Headshaking in horses is a major welfare issue and can be a significant cause of distress.
"Although it is clear that further work is required, including increasing the number of cases and refining the treatment procedures, the study shows that PENS therapy should be the first-line treatment for trigeminal-mediated headshakers, which have failed to respond to conservative treatment, such as nose-nets."
Reference
The company says it is a further step forward in its plans to expand into Europe and follows the launch of its online pharmacy business, Animed Direct, into France during 2016. It adds that further acquisitions are expected in Europe during 2017, in addition to continued growth in the UK.
The two Dutch practices joining CVS are the Kliniek voor Gezelschaps Dieren, a three site small animal practice based in the central Netherlands, and a single site small animal practice, Dierenziekenhuis Drachten, based in the north of the country. Both practices cited the business support and staff development opportunities offered by CVS, combined with the clinical freedom and practice autonomy it allows, as the reasons for choosing to join the company.
Simon Innes, CEO at CVS, said: "We see many parallels between small animal practice in the Netherlands and the UK and have been talking to practices in the country about the benefits of joining us for some time. The level of interest has been encouraging and we are delighted to announce the acquisition of these two practices and welcome their teams to the CVS family.
"During 2017, we will continue to explore opportunities to extend our activities into Europe, particularly in the Netherlands and in Ireland."
The survey asks EU nationals about their experience of practising in the UK since the referendum and will seek to find out what their career expectations and aspirations are now.
The survey will also ask how they feel that the RCVS has supported EU vets to practise in the UK since the transition period ended on 31 December 2020.
The survey is being conducted by the Institute for Employment Studies (IES), an independent, not-for-profit research institute.
Respondents are encouraged to be as open as possible, as individual responses will not be seen by the RCVS and all survey data will be analysed independently by IES.
Lizzie Lockett, RCVS CEO said: “We are hearing anecdotal feedback from EU veterinary professionals about the impact of the EU Exit on their working lives, but it is important for us to have direct feedback as evidence for our recommendations.
"I would encourage everyone who receives the survey to share their thoughts with us, as the feedback we receive from this and the previous surveys, will help us to plan what training, resources and support the professions need from us post-EU Exit."
Everyone eligible to take part in the survey is being sent an email today from Dilys Robinson at the IES, with a link to the survey.
You have until Tuesday 16th November 2021 to complete it.
If you have any questions, contact Sara.Butcher@employment-studies.co.uk.
At 9.00am on Thursday and 1.45pm on Friday, Dr Sam Taylor, Feline Specialist and academy lead at the International Society of Feline Medicine (ISFM), will present ‘feline pawsative’, a talk about about cat inappetence and the remedy offered by Mirataz.
At 11.20am on Thursday and 9.00am on Friday, Matt Gurney, clinical director at Anderson Moores will be sharing the latest developments in sedation in dogs including Zenalpha.
At 12.30pm on Thursday and 12.35pm on Friday, Andrew Waller (pictured right), chief scientific officer at Intervacc AB, will be discussing how to rein in the impact of strangles using Dechra’s new protein-based vaccine, Strangvac.
The CPD sessions are first come, first served, and Dechra says it expects the presentations to be well-attended, so it could be worth getting there a little early, although probably no need to pitch a tent outside the night before.
A similar scheme will also be run for Australian colleagues wanting to spend time in the UK.
The programme will allow the company's vets to enhance their role internationally and to explore other parts of the world whilst furthering their career.
The programme is open to vets with over one year's experience, who want to work overseas and then return to their current practice afterwards.
Secondments are also available for staff in support office roles.
Staff will be able to return to their existing roles for up to 12 months, and thereafter a similar role will be made available to them in their region.
Graeme Cramb, Managing Director for CVS Australia, said: “Our vision is to be the veterinary company that most people want to work for and we believe this UK-Australia secondment scheme represents an attractive option for colleagues.
“As the first vet company to offer a UK-Australia secondment scheme, we hope that it enables our colleagues to learn from colleagues in a new territory, further their career and to lead to some exciting cross-pollination of ideas.”
When colleagues express an interest, they will be contacted by CVS recruitment team member to discuss potential opportunities that they can apply for.
They must meet the criteria required to be able to obtain a visa to work in Australia.
Successful applicants will be offered a relocation package and continue to be paid their salary in the UK.
They may also be eligible for the cost of living allowance, paid in Australia.
https://www.careerswithcvs.co.uk/intranet/vacancy/uk-to-australia-secondment-program-4472/18753/description/
New research amongst veterinary professionals conducted by CEVA Animal Health, manufacturer of D.A.P.® and Feliway®, has revealed that pet owners may be unintentionally fuelling their pets' noise phobias in the run up to the fireworks' season.
According to CEVA's research, up to 95% react inappropriately, for example petting an anxious pet during firework exposure rather than making an effort to ignore the fireworks, thereby reassuring the animal by behaving normally.
The research also suggested that 77% of clients have never taken action to address their pets' noise phobias as fireworks' season is only an annual occurrence. This is despite evidence that noise phobias can affect pets all year round and tend to become worse over time.
In addition, if owners do seek advice from their vet for noise phobias, it is at the last minute. It is estimated that 46% of clients leave it until the day before the fireworks are due to start before seeking help.
Lucy Brett, product manager at CEVA Animal Health said: "Owners are not doing enough to reduce their pets' firework fears and prevent noise phobias from developing.
"Taking early, proactive action within the practice is the best way to help dogs with pre-existing firework phobias as well as those with mild fears which, if left untreated, may develop into more serious noise phobias."
CEVA Animal Health and Sound Therapy 4 Pets have once again joined forces with the Association of Pet Behaviour Counsellors (APBC), Feline Advisory Bureau (FAB) and PDSA to launch a 'Remember, remember your pets this November' campaign to provide owners with advice on how to look after their pets during the firework season and the precautions they should take to help them cope with their fear of fireworks.
The initiative features a wide range of advice including how to use synthetic copies of natural pheromones, D.A.P. ® and Feliway®, to help comfort and reassure fearful pets, creating a comforting den for dogs to retreat to during firework exposure and treating noise phobias using behavioural therapy with the Sounds Scary desensitisation CD (which is the only behavioural therapy product for noise phobias supported by the RSPCA).
For further information, please visit www.petfireworkfear.co.uk.
Dechra Pharmaceuticals has signed an agreement with Piedmont Pharmaceuticals LLC which gives Dechra exclusive worldwide rights to the sale and distribution of veterinary products which use Piedmont's proprietary soft chew platform to deliver the active ingredient.
The agreement will allow Dechra to conduct studies necessary to achieve regulatory filings and government approvals within the US, Europe and other key countries.
According to Dechra, Piedmont's soft chew formulation is a unique delivery technology which overcomes the traditional problems in formulating a broad range of active drug compounds in a highly palatable chewy treat for both cats and dogs.
Ian Page, CEO of Dechra Pharmaceuticals PLC, said: "We are very excited about licensing this unique delivery technology, which will be the first soft chew product with this new patent pending technology in the veterinary market. The agreement will provide Dechra with the opportunity to expand our presence in the companion animal market with a truly differentiated product."Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, said: "This is our initial development partnership for our soft chew technology and we welcome the opportunity to license our technology to Dechra. Our goal is to provide pet owners the added benefit of a tasty treat at medicine time, creating a fun and rewarding interaction, while improving compliance with the vet prescribed treatment regimen."
Over 100 students from Nottingham Vet Society will attempt the 3 Peaks Challenge by climbing Ben Nevis, Scafell Pike and Snowdon in under 24 hours on 10 March.
The funds raised will be split between VBF, the charity that supports veterinary professionals, and Medical Detection Dogs.
Online donations can be made at http://goo.gl/IkodW.
Lydia Brown, VBF President, said: "We are so grateful to the students involved who organized this off their own backs even though they don't have much free time. It augurs well for the future of the profession that they want to support their colleagues. I do hope they all make it back to Nottingham safely and I look forward to seeing the pictures on facebook.com/VetlifeVBF! "
Tom McKay, one of the students who organized the challenge, said: "We have really enjoyed the training and are reasonably optimistic we will make it back for our Easter placements!"
Animalcare has announced that Buprecare buprenorphine single dose ampoules are now back in stock and ready to order from all veterinary wholesalers.
Production of the product had ceased in July 2011, when the company's previous manufacturer closed its sterile production unit.
Animalcare says that since then, it has been working to identify a reliable, high quality manufacturer which will be able to meet demand. The company has now signed a new contract with a German company which operates a substantial sterile injectables manufacturing facility in France. This facility is approved to manufacture Buprecare single dose ampoules and has produced, tested, quality assured and shipped its first batches.
Stephen Wildridge, CEO of Animalcare Group plc, said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly. However after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position. It’s a very good way to start 2013.”
Available in the familiar 5 x 1ml pack, the Buprecare single dose ampoules now have a ‘one-point-cut’ design giving greater assurance of a clean ‘snap’ when opening the ampoule, enhancing the safety of the user.
Additional support is also now available to veterinary practices that purchase Buprecare ampoules or multidose vials, including CPD pain management talks and a peer-reviewed pain assessment chart.
The BSAVA has launched the BSAVA Manual of Canine and Feline Radiography and Radiology with a new introductory text aimed at veterinary students, nurses and new graduates.
The Association says confident radiographic interpretation presents a considerable challenge and the BSAVA Manual of Canine and Feline Radiography and Radiology provides a comprehensive review of the approach to radiological interpretation, the range of variants and the key fundamental principles and their application to common diseases.
The manual features high quality radiographic reproductions demonstrating normal anatomy and key aspects of interpretation, as well as illustrations showing patient positioning and the practical approach that is the hallmark of the BSAVA manuals.
The book contains the following contents:
An extra feature is the CD, which contains all the radiographic images from the manual, so that readers can view the many images at an enlarged size.
The manual is available from October and can be ordered from www.bsava.com.
Almost all rabies cases are as a result of being bitten by an infected dog, with around half of all dog bites and rabies deaths occurring in children under 15 years of age. Rabies, which is preventable, is categorised as one of the 17 Neglected Tropical Diseases by the World Health Organization (WHO).
The End Rabies Now campaign aims to significantly raise the profile of rabies as a global neglected tropical disease with policy makers and journalists, explaining what is being done to control and eliminate the disease. The campaign is led by Global Alliance for Rabies Control (GARC), and has three key messages:
Ahead of the tenth World Rabies Day, BVA has also recognised vet Professor Sarah Cleaveland OBE for her work in rabies control by awarding her the Chiron Award, one of the Association’s most prestigious awards for outstanding contributions to veterinary science.
Sarah said: "Awards like this are recognition of the contributions not only of one person, but the work of many. We are deeply committed to continuing our efforts towards the global elimination of canine rabies and tackling other zoonotic diseases that affect the health and livelihoods of many of the poorest people in the world."
The End Rabies Now campaign is based around the strong scientific evidence that vaccinating dogs is fundamental to disrupting the cycle of rabies transmission to humans. The target of 2030 was chosen because one of the UN’s sustainable development goals, launched in September 2015, includes the ambition to end by 2030 neglected tropical diseases such as rabies.
With 120 countries still affected by canine rabies, the End Rabies Now campaign advocates that collaborative cross-sector efforts are needed to end zoonotic diseases such as rabies: rabies elimination plans must include human and animal government agencies, veterinary and human health professionals, educators, scientists and community groups.
BVA President Gudrun Ravetz said: "The work being done worldwide by vets, human health professionals and others to combat this horrific disease that senselessly kills thousands each year is of the utmost importance and BVA is proud to support the End Rabies Now campaign and help get those key messages out to policy makers and governments worldwide – every rabies death is entirely preventable and we can end rabies by 2030 through vaccinating dogs."
The guidance has been in place since March to help practices continue to provide the public with veterinary services whilst safeguarding the health of their teams and clients.
The RCVS Council Covid-19 Taskforce reviewed the situation on 30th July and decided to extend the guidance after taking into account the pandemic’s progress, the latest government guidance, the headline results from a survey of practice experience of remote consulting, and 'other data from a number of veterinary practices'.
The Taskforce says it also considered the need to continue to provide practices with flexibility in the face of possible local or national lockdowns, the need for inclusivity of those practice teams members and clients who may still be shielding, the likelihood of quarantine of members of the team due to travel and/or Test and Trace and the fact that no major safety issues had been identified as part of the RCVS-commissioned survey into the immediate impact of the temporary guidance.
RCVS President Mandisa Greene, who chairs the Taskforce, said: “Whilst lockdown measures have been eased and matters have improved, we are far from being back to business as usual and the threat of returning to more severe lockdown measures, whether locally or nationally, is still very much alive."
The updated flowchart, along with all the College’s coronavirus guidance for the professions, is available at: www.rcvs.org.uk/coronavirus.
The College says the reforms will make for a clearer and more streamlined process, and offer an alternative, more compassionate way of resolving cases that might otherwise go to a full Disciplinary Committee hearing.
The College will now establish ‘Stage 1 Preliminary Investigation Committees (PICs)’ to replace the current Case Examiner Group stage of the concerns investigation process.
Eleanor Ferguson, RCVS Registrar, said: “Setting up Stage 1 PICs will streamline and clarify the early stages of the concerns investigation process and could also potentially, once sufficiently bedded in, reduce the amount of time taken for a number of cases.
“Currently, Stage 1 of a concerns investigation is carried out by a Case Examiner Group who determine if there is an ‘arguable case’ for serious professional misconduct before referring it on to the Preliminary Investigation Committee.
"However, under these reforms, the Stage 1 PICs will close cases where there is no realistic prospect of finding a case of serious professional misconduct.
"Where cases require formal statements and/or expert opinion they will be referred on to Stage 2 PIC to determine if, based on the additional evidence gathered, a case is serious enough to warrant referral to either the Charter Case Committee [see below], or a full, public Disciplinary Committee hearing.
“In essence this change means that there will be one consistent threshold of seriousness in all our investigations, meaning it is likely that fewer cases will be unnecessarily referred to Stage 2 of the process.”
The second reform involves the implementation of the new ‘Charter Case Protocol’ to provide an alternative way to resolve suitable cases meeting certain criteria which, though they meet the threshold to go to the Disciplinary Committee, it is considered that the public interest can still be served without a full hearing.
The ‘Charter Case Committee’ to which these cases will be referred will be able to issue written warning notices.
Eleanor added: “The establishment of the Charter Case Protocol and Committee is important for the RCVS in being able to get the balance right between upholding professional conduct standards and protecting animal health and welfare and public confidence in the professions, while also being a compassionate regulator.
“The type of cases we envisage being dealt with by the Committee are those where the conduct of the veterinary surgeon or veterinary nurse has fallen far short of what is expected of them under the Code, but where there is no ongoing risk to animal welfare or public confidence, and where the level of insight and contrition about their conduct is such that it can be resolved without the need for an onerous, stressful and expensive Disciplinary Committee hearing.
"We estimate that the Charter Case Committee will deal with around 20 such cases per year.
“Of course, the most serious cases of professional misconduct, for example around dishonesty and criminality, will continue to be referred to Disciplinary Committee hearings.
“It is worth noting that Charter Case Protocol and Committee are working titles, describing the fact that we are implementing this process under the remit of our Royal Charter.
"RCVS Council has agreed that the name should be changed in due course to something that better reflects its function and remit."
Unlike the Disciplinary Committee, the Charter Case Committee will not issue to the press the full details of cases as a news article.
Instead, it will publish a warning notice on the RCVS website summarising the area of concern, the relevant sections of the Code that were breached and supporting guidance it referred to, and the reasons for issuing the warning.
These warning notices will remain on the RCVS website for a maximum of two years and will not change the registration status of the individual.
The College says that the reforms are likely to take some months to implement and it will be looking to recruit additional Preliminary Investigation Committee members in due course.
Animal Friends Insurance (AFI), a not-for-profit pet insurance business, has a High Court injunction which paves the way for its customers to make a smooth transition from the company's previous underwriters, Equine and Livestock Insurance Company (E&L), to Red Sands Insurance Company (Europe) Limited.
Equine and Livestock terminated their underwriting agreement with AFI in February 2008, citing unprofitablility of the book for them as the reason.
Negotiations over the transfer of the book to Red Sands Insurance Company (Europe) Limited foundered when E&L demanded £750,000 from AFI for the transfer and for their agreement not to solicit AFI customers.
Following legal advice AFI wrote to its customers offering to renew policies with Red Sands. This spawned letters to AFI customers from E&L which caused great confusion amongst customers as to what was happening with their insurance. The letters also offered first a 10% then a 20% discount to tempt AFI customers to renew with E&L and not to stay with AFI.
AFI therefore applied for an emergency injunction to prevent E&L making further contact with AFI customers (except in agreed situations, notably claims), to stop the escalating confusion and also to require them to acknowledge renewals advised to them by AFI into Red Sands and not to take further payments on those insurances. The application was successful.
Elaine Fairfax, Managing Director and Founder of AFI said: "I am delighted at the Court ruling. It has resolved the terrible confusion that followed E&L's letters to our customers. Unfortunately we know that some customers said they would renew with E&L thinking they were staying with us! Now we can simply renew our customers' policies with our new underwriters as we had originally intended to do at no inconvenience to them as they need do nothing if they want to stay with Animal Friends. They will enjoy exactly the same policy terms and premiums as before and our underwriters will even take on existing ongoing conditions where a policyholder has lifetime cover."
She added: "Although this has been a horrible experience we are delighted to have new underwriters as they have given us authority to handle everything in-house. For vets this means that Animal Friends will now be handling claims at our Wiltshire H.Q. We have a bespoke pet claims software systems and veterinary nurse staff to give the best possible service. We have the facility to pay claims swiftly direct into a customer's bank account or direct to a vet. It is also exciting that we shall be able to draw on Hollard's* international pet insurance experience to introduce some unique new products and ideas into the UK pet insurance market in the near future."
Ceva Animal Health has highlighted a new meta-analysis1 which, according to the company, reveals that there is a significant (P< 0.001) association between the use of pharmacotherapy (fluoxetine and clomipramine) or pheromonatherapy (Feliway) and reduction or elimination of feline urine marking.
Ceva says this is the first time a meta-analysis technique has been used to evaluate the efficacy of interventions in veterinary behavioural medicine; the study assessed all published papers covering treatments for feline urine spraying. Ten studies in nine publications were analysed, despite their different study designs. In order to carry out the meta-analysis, the papers were rated according to importance and a 'placebo-effect' was calculated. Primary and secondary outcomes were also identified, with the primary outcome being the 'number of cats that either ceased or reduced spraying by at least 90%' and the secondary outcome being 'the number of cats that reduce spraying from baseline levels'.
Information is available by calling Lucy Brett at CEVA Animal Health on 01494 781510.
1. A meta-analysis of studies of treatments for feline urine spraying. Daniel S Mills, Sarah E Redgate, Gary M Landsberg. PLos ONE, April 2011, Volume 6, Issue 4
Under the Petplan Portfolio Rewards scheme, each time a practice generates a full policy (including clients continuing cover from IVC /4 week free policies) they earn Portfolio Rewards credits.
A practice issuing Immediate Veterinary Cover (IVC) ordinarily earns 150 credits when the client continues their cover onto a full policy but, during this promotion, a full policy generated by an IVC will earn 300 credits, equivalent to £12.
Credits can then be exchanged against a range of products, from essential veterinary equipment and specialised literature to a variety of indulgences including chocolates and bottles of wine, leisure activities or team nights out.
Head of Sales & Partnerships at Petplan, James Barnes said: "Petplan is the UK’s no 1 pet insurance provider and our unique relationship with the veterinary profession remains an important part of our success so we wanted to do something extra to thank practices for their efforts promoting Petplan insurance to their clients during 2016. We know many practices like to exchange their Portfolio Rewards at Christmas so this promotion gives practices the chance to boost their account before the festive season."
For further information about the scheme or working with Petplan, visit petplanvet.co.uk.
Having sold Belgravia House – its Westminster offices since 1995 – to a private investor in March 2021 for £14.5m, RCVS Council agreed the purchase of the new building for £20.5m.
The additional cost has been funded from College reserves.
The new building is a converted Victorian warehouse with open-plan office space spread across six floors.
The new premises are large enough to accommodate more staff and for the College to host more meetings and events.
Alternatively, the space can be used for greater social distancing and hybrid working if needed.
The College says any unwanted space can be rented out.
Two existing tenants will continue to lease office space at the premises for the time being and some refurbishment work will need to be completed before the College and RCVS Knowledge teams can start moving in.
Following Council’s earlier decision to terminate the lease on Belgravia House at the end of March 2022, RCVS staff will continue to work either remotely, or in temporary office space leased from the workplace provider, WeWork, in Chancery Lane.
The College says this arrangement offers a significant saving over leasing back Belgravia House.
Chief Executive Lizzie Lockett said: “Like any property purchase, it has been an extremely long and difficult journey to get to this point, with many challenges to navigate along the way, but I am delighted that we are finally able to announce our new home.
“Whilst we will have to wait a while longer before we can enjoy everything 1-2 Hardwick Street has to offer, we are very much looking forward to welcoming members of the professions to visit our new offices, and being able to host a variety of meetings and new events there for them.
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
The webinar is presented by Will Stirling, partner at VetsDigital, a digital marketing agency which supports the veterinary industry across Europe.
Will will offer practical advice and guidance on the growing importance of applying digital marketing and the effect it can have on both team morale and the bottom line.
To register for the webinar, visit to: https://tinyl.io/5aIi
Veterinary surgeon Andrew Reeder, Director of the Stonehenge Veterinary Hospital, in Durrington, near Salisbury, was the lucky winner of a Sony Pocket e-Reader in the Royal College of Veterinary Surgeons' prize draw at the London Vet Show in November.
The competition was mounted to launch an online quiz to test members' knowledge of the Guide to Professional Conduct. All those who completed the quiz on the RCVS stand at the event were entered into a prize draw: the RCVS would like to stress that it was a random draw, in spite of the serendipity of Andrew's surname!
"This is brilliant, I so rarely win anything!" said Andrew. "I'd recommend that all RCVS members should have a go at the quiz - it's quick, easy to complete and certainly makes you think."
Over 600 people have tackled the quiz so far. Those who fancy testing their knowledge of the Guide should visit www.rcvs.org.uk/guidequiz. The quiz is anonymous, but the College will be collating data to help focus future communications activities and see where extra guidance may be required. On completion of the quiz, it is possible to review answers and view the relevant section of the online Guide.